State Anxiety (STAI) scores of study subjects
| Follow-up assessment of STAI | Participant group; mean STAI score (and SD)* | |
|---|---|---|
| Naltrexone | Methadone | |
| Subjects who attended all assessments | n = 9 | n = 8 |
| Baseline | 34.9 (14.7) | 38.1 (14.4) |
| 1 mo | 37.9 (17.2) | 38.6 (17.1) |
| 2 mo | 29.0 (12.2) | 38.3 (16.1) |
| 3 mo | 34.6 (9.0) | 41.1 (12.5) |
| 6 mo | 34.8 (11.7) | 37.6 (12.9) |
| Existing data, without imputation | ||
| Baseline | n = 42 | n = 38 |
| 35.7 (12.0) | 37.6 (12.4) | |
| 1 mo | n = 28 | n = 14 |
| 42.0 (15.6) | 36.5 (15.7) | |
| 2 mo | n = 19 | n = 16 |
| 35.6 (14.9) | 40.4 (14.7) | |
| 3 mo | n = 21 | n = 26 |
| 38.1 (10.8) | 41.9 (10.4) | |
| 6 mo | n = 13 | n = 28 |
| 35.8 (11.8) | 38.8 (11.8) | |
| Intention to treat,† n = 80 | n = 42 | n = 38 |
| Baseline | 35.7 (12.0) | 37.6 (12.4) |
| 1 mo | 40.3 (14.3) | 37.4 (13.1) |
| 2 mo | 37.4 (13.7) | 38.3 (13.0) |
| 3 mo | 39.1 (11.7) | 40.8 (11.6) |
| 6 mo | 39.1 (12.6) | 39.0 (12.6) |